Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X
    4.
    发明授权
    Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X 有权
    糖缀合物及其用作针对志贺氏菌志贺氏菌血清型3a和X的疫苗

    公开(公告)号:US08815239B2

    公开(公告)日:2014-08-26

    申请号:US12663454

    申请日:2008-05-16

    摘要: The present invention relates to compounds derived from sugars which reproduce the epitopes of Shigella flexneri serotypes 3a and X and to the use thereof for the preparation of vaccine compositions. More specifically, the subject matter of the present invention relates to novel glycoconjugated compounds comprising oligosaccharides or polysaccharides described hereinafter, to the method for synthesizing these oligosaccharides or polysaccharides and glycoconjugates, to derivatives of these oligosaccharides or polysaccharides, to compositions containing same, and also to the use of the glycoconjugates for vaccination purposes. Finally, the present invention relates to methods for diagnosing a Shigella flexneri infection using one or more oligosaccharides or polysaccharides or conjugates thereof.

    摘要翻译: 本发明涉及衍生自富含志贺氏菌志贺氏菌血清型3a和X的表位的糖的化合物及其制备疫苗组合物的用途。 更具体地,本发明的主题涉及包含下文所述的寡糖或多糖的新型糖缀合化合物,涉及将这些寡糖或多糖和糖缀合物合成的方法,这些寡糖或多糖的衍生物用于含有它们的组合物,还涉及 使用糖缀合物进行疫苗接种。 最后,本发明涉及使用一种或多种寡糖或多糖或其结合物诊断志贺氏杆菌感染的方法。